$5.59B
$2.85 Million
0.01% of portfolio
79,991
Q1 2025
Added 5.43%
$10.4B
$1.48 Million
0.01% of portfolio
9,025
Q1 2025
Reduced 5.93%
$29.7B
$1.36 Million
0.01% of portfolio
13,304
Q1 2025
Reduced 8.15%
$8.28B
$2.01 Million
0.01% of portfolio
22,600
Q4 2024
Added 20.21%
$14.1B
$2.41 Million
0.01% of portfolio
196,500
Q4 2024
Reduced 11.65%
$7.4B
$629,000
0.0% of portfolio
77,300
Q4 2024
Added 0.52%
$1.16B
$620,000
0.0% of portfolio
44,000
Q4 2024
Added 6.02%
$2.98B
$682,000
0.0% of portfolio
14,409
Q4 2024
Added 11.62%
$823M
$240,000
0.0% of portfolio
9,816
Q4 2024
Reduced 7.54%
$2.49B
$739,000
0.0% of portfolio
11,723
Q4 2024
Reduced 0.85%
$2.2B
$814,000
0.0% of portfolio
35,800
Q4 2024
New
$4.33B
$1.05 Million
0.0% of portfolio
13,700
Q4 2024
Added 12.3%
$3.71B
$930,000
0.0% of portfolio
20,400
Q4 2024
Reduced 8.11%
$1.99B
$624,000
0.0% of portfolio
20,574
Q1 2025
Reduced 3.29%
$3.92B
$911,000
0.0% of portfolio
54,833
Q4 2024
Added 15.12%
$1.92B
$776,000
0.0% of portfolio
37,032
Q4 2024
Added 12.45%
$10.9B
$1.21 Million
0.0% of portfolio
4,600
Q4 2024
Added 64.29%
$5.26B
$721,000
0.0% of portfolio
10,500
Q4 2024
Added 15.38%
$1.2B
$168,000
0.0% of portfolio
15,500
Q2 2024
Reduced 7.19%
$1.74B
$404,000
0.0% of portfolio
4,083
Q4 2024
Added 17.23%
$1.63B
$301,000
0.0% of portfolio
22,800
Q4 2024
Added 20.63%
$6.18B
$825,000
0.0% of portfolio
8,195
Q1 2025
Reduced 2.38%
$3.77B
$502,000
0.0% of portfolio
12,800
Q2 2024
Reduced 47.11%
$5.89B
$995,000
0.0% of portfolio
10,437
Q4 2024
Added 11.78%
$2.68B
$381,000
0.0% of portfolio
5,259
Q3 2024
Added 20.65%
$1.99B
$566,000
0.0% of portfolio
19,323
Q4 2024
Added 8.42%
$468M
$325,000
0.0% of portfolio
75,000
Q4 2024
Added 47.93%
$1.99B
$850,000
0.0% of portfolio
21,000
Q4 2024
Added 5.0%
$7.42B
$1.12 Million
0.0% of portfolio
22,700
Q2 2024
Added 15.82%
$1.35B
$384,000
0.0% of portfolio
22,303
Q1 2025
Added 13.77%
$1.58B
$689,000
0.0% of portfolio
116,200
Q4 2024
Reduced 16.52%
$2.3B
$323,000
0.0% of portfolio
12,300
Q4 2024
New
$5.88B
$784,000
0.0% of portfolio
31,200
Q1 2025
Reduced 14.29%
$3.14B
$536,000
0.0% of portfolio
10,700
Q4 2024
Reduced 23.57%
$3.28B
$727,000
0.0% of portfolio
7,851
Q4 2024
Added 25.6%
$1.25B
$298,000
0.0% of portfolio
14,802
Q4 2024
Added 17.46%
$3.72B
$546,000
0.0% of portfolio
46,992
Q4 2024
Added 16.63%
$2.65B
$1.08 Million
0.0% of portfolio
13,665
Q1 2025
Reduced 0.16%
$5.14B
$894,000
0.0% of portfolio
15,530
Q3 2024
Added 25.95%
$2.24B
$714,000
0.0% of portfolio
87,441
Q3 2024
Added 15.14%
$6.52B
$287,000
0.0% of portfolio
15,876
Q1 2025
Reduced 45.96%
$1.48B
$327,000
0.0% of portfolio
39,000
Q4 2024
New
$1.32B
$417,000
0.0% of portfolio
14,400
Q4 2024
Reduced 14.79%
$1.13B
$484,000
0.0% of portfolio
54,948
Q3 2024
Added 33.86%
$2.54B
$669,000
0.0% of portfolio
30,600
Q4 2024
Added 10.87%
$1.48B
$405,000
0.0% of portfolio
42,302
Q4 2024
Added 16.53%
$1.66B
$276,000
0.0% of portfolio
8,900
Q4 2024
Added 4.71%
Apogee Therapeutics Inc Com
-
$280,000
0.0% of portfolio
-
Q4 2024
Reduced 14.77%
$1.29B
$248,000
0.0% of portfolio
8,600
Q4 2024
Added 14.67%
$2.85B
$997,000
0.0% of portfolio
77,218
Q4 2024
Reduced 8.53%